首頁 > 市場調查報告書 > 食物/飲料

機能性食品

維生素K2市場規模、佔有率和成長分析（按功能、產品類型、形態、來源、應用和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1899250

維生素K2市場規模、佔有率和成長分析（按功能、產品類型、形態、來源、應用和地區分類）－2026-2033年產業預測

Vitamin K2 Market Size, Share, and Growth Analysis, By Function (Bone and Cardiovascular Health, Blood Health and Clotting), By Product Type (MK-4, MK-7), By Form, By Source, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 160 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，維生素 K2 市場規模將達到 1.8422 億美元，到 2025 年將達到 2.0983 億美元，到 2033 年將達到 5.9437 億美元，在預測期（2026-2033 年）內複合年成長率為 13.9%。

維生素K2市場預計將迎來顯著成長，這主要得益於消費者對其健康益處的認知不斷提高、人口老齡化等人口趨勢以及消費者對機能性食品日益成長的興趣。維生素K2對心血管和骨骼健康的正面作用已得到公認，隨著消費者更加重視慢性病預防和整體健康，對維生素K2補充劑的需求也隨之增加。研究不斷證實其治療益處，進一步激發了人們對維生素K2的興趣。此外，骨質疏鬆症和心血管疾病等日益嚴重的健康問題凸顯了對高效能維生素K2產品的需求。這種必需營養素能夠促進鈣質沉積於骨骼，從而降低骨折風險，並且在降低心臟病和動脈鈣化方面也展現出良好的效果，進一步推動了市場擴張。

維生素K2市場促進因素

隨著人們對維護骨骼健康重要性的認知不斷提高，維生素K2市場正經歷顯著成長。公共衛生措施的加強和媒體的廣泛報導凸顯了維生素K2在骨骼礦化和預防骨質疏鬆症方面的作用，從而激發了消費者的關注。這種意識的提高導致需求顯著成長，因為人們希望保持骨骼強健並降低骨折風險。加強對維生素K2促進骨骼密度益處的公共教育，鼓勵了消費者的參與，並大大促進了市場的擴張。

維生素K2市場限制

由於優質維生素K2補充劑高成本，維生素K2市場面臨嚴峻挑戰。許多優質產品，尤其是採用高生物利用度形式（例如MK-7）配製的產品，定價較高，令注重成本的消費者難以負擔。這種經濟障礙可能導致潛在客戶完全放棄維生素K2補充劑，或選擇價格更低但功效可能不相上下的替代品。因此，消費者不願投資購買優質產品阻礙了維生素K2的廣泛普及和使用，在日益注重健康的市場環境下，限制了其整體市場成長潛力。

維生素K2市場趨勢

維生素K2市場正經歷顯著成長，這主要得益於消費者對機能性食品日益成長的興趣，這些食品不僅提供基本的營養補充，還能帶來健康益處。隨著注重健康的消費者尋求有助於提升整體健康的產品，製造商正積極將維生素K2添加到各種產品中，包括植物來源替代品、強化乳製品和營養點心棒。這一趨勢反映了更廣泛的健康意識提升趨勢，隨著消費者積極尋求有益於整體健康的成分，維生素K2市場正在不斷擴大。因此，添加維生素K2的產品預計將會增加，從而吸引更多尋求營養選擇的消費者。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

AlloSource（US）
Smith+Nephew（UK）
Medtronic（Ireland）
Orthofix US LLC（US）
Zimmer Biomet（US）
Geistlich Pharma AG（Switzerland）
Stryker（US）
Biobank（UK）
DSM Nutritional Products（Switzerland）
Pharmavit（India）
Viridis BioPharma Pvt. Ltd.（India）
Lactonova Nutripharm Pvt. Ltd.（India）
Gencor Pacific Inc.（US）
NuScience Trading, LLC（US）
NutriScience Innovations LLC（US）
ExcelVite Sdn. Bhd.（Malaysia）
Parchem Fine & Specialty Chemicals（US）
Avanscure Lifesciences Pvt. Ltd.（India）
Health Thru Nutrition（US）
Ampak Company, Inc.（US）
Arnet Pharmaceutical（US）
Swanson Health Products（US）
AIDP, Inc.（US）
Ortho Molecular Products（US）
Evesa Nutritionals（India）

簡介目錄

Product Code: SQMIG35I2355

Vitamin K2 Market size was valued at USD 184.22 Million in 2024 and is poised to grow from USD 209.83 Million in 2025 to USD 594.37 Million by 2033, growing at a CAGR of 13.9% during the forecast period (2026-2033).

The vitamin K2 market is poised for significant growth driven by heightened consumer awareness of its health benefits, demographic trends such as an aging population, and a growing interest in functional foods. Recognized for its positive impacts on cardiovascular and bone health, the demand for vitamin K2 supplements is increasing as consumers prioritize prevention of chronic illnesses and overall well-being. Research continues to underline its therapeutic potential, further fueling interest. Additionally, the rise in health concerns, notably osteoporosis and cardiovascular issues, emphasizes the necessity for effective vitamin K2 products. This essential nutrient aids in directing calcium to bones, thereby lowering fracture risk, and has shown promise in reducing cardiac issues and arterial calcification, contributing to a growing market presence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vitamin K2 market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vitamin K2 Market Segments Analysis

Global Vitamin K2 Market is segmented by Function, Product Type, Form, Source, Application, and region. Based on Function, the market is segmented into Bone and Cardiovascular Health, Blood Health and Clotting, and Anti-Inflammatory and Immunity, Other Functions. Based on Product Type, the market is segmented into MK-4, and MK-7. Based on Form, the market is segmented into Capsules &Tablets, Powder and Crystalline, Liquids, and Others. Based on Source, the market is segmented into Natural, and Synthetic. Based on Application, the market is segmented into Pharmaceuticals, Functional Foods and Beverages, Health Supplements. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Vitamin K2 Market

The Vitamin K2 market has experienced substantial growth as individuals become increasingly aware of the importance of maintaining bone health. Enhanced public health initiatives and extensive media coverage have highlighted the role of Vitamin K2 in bone mineralization and osteoporosis prevention, thereby capturing the interest of consumers. This heightened awareness has led to a notable increase in demand as people seek to maintain strong bones and reduce their risk of fractures. The focus on educating the public about the benefits of Vitamin K2 in promoting bone density has fostered a proactive approach among consumers, significantly contributing to the market's expansion.

Restraints in the Vitamin K2 Market

The Vitamin K2 market faces significant challenges due to the high costs associated with premium supplements. Many high-quality options, particularly those incorporating bioavailable forms like MK-7, come with a steep price tag, making them less accessible to cost-sensitive consumers. This financial barrier may lead potential customers to either forgo Vitamin K2 supplementation altogether or opt for lower-priced alternatives that may not offer the same efficacy. Consequently, this reluctance to invest in quality products hinders broader acceptance and usage of Vitamin K2, ultimately limiting the overall growth potential of the market in a increasingly health-conscious landscape.

Market Trends of the Vitamin K2 Market

The vitamin K2 market is experiencing significant growth, driven by the rising consumer interest in functional foods that extend beyond basic nutrition to offer enhanced health benefits. As health-conscious individuals seek out products that contribute positively to their well-being, manufacturers are increasingly incorporating vitamin K2 into a diverse array of offerings, including plant-based alternatives, fortified dairy items, and nutritious snack bars. This trend reflects a broader wellness movement, with consumers actively pursuing ingredients that support overall health, thus expanding the market for vitamin K2. As a result, the availability of vitamin K2-enriched products is set to increase, attracting a wider customer base seeking enhanced nutritional options.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Case Study Analysis
Regulatory Landscape
Patent Analysis
Pricing Analysis
Technology Analysis
Trade Analysis
Customer & Buying Criteria Analysis

Vitamin K2 Market by Function

Market Overview
Bone And Cardiovascular Health
Blood Health And Clotting
Anti-Inflammatory And Immunity
Other Functions

Vitamin K2 Market by Product Type

Market Overview
MK-4
MK-7

Vitamin K2 Market by Form

Market Overview
Capsules And Tablets
Powder And Crystalline
Liquids
Others

Vitamin K2 Market by Source

Market Overview
Natural
Synthetic

Vitamin K2 Market by Application

Market Overview
Pharmaceuticals
Functional Foods and Beverages
Health Supplements

Vitamin K2 Market Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

AlloSource (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith + Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix US LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Geistlich Pharma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biobank (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DSM Nutritional Products (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmavit (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viridis BioPharma Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lactonova Nutripharm Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gencor Pacific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuScience Trading, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NutriScience Innovations LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ExcelVite Sdn. Bhd. (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parchem Fine & Specialty Chemicals (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanscure Lifesciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Health Thru Nutrition (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ampak Company, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arnet Pharmaceutical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Swanson Health Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AIDP, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Molecular Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evesa Nutritionals (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments